Hormone replacement therapy and previous use of oral contraceptives among Swedish women

被引:37
|
作者
Hammar, M
Brynhildsen, J
Dabrosin, L
Frisk, J
Lindgren, R
Nedstrand, E
Wyon, Y
机构
[1] Dept. of Obstetrics and Gynaecology, Faculty of Health Sciences, University Hospital, Linköping
关键词
hormone replacement therapy; alternative remedies; menopause; oral contraceptives;
D O I
10.1016/S0378-5122(96)01065-1
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Objectives: To assess the current and previous use of hormone replacement therapy (HRT) and alternative remedies in a postmenopausal population and to relate HRT use to previous use of oral contraceptives. Material and methods: All 1323 women living in Linkoping of 55 or 56 years old during 1995 were sent a questionnaire asking for data with relation to health and climacteric symptoms as well as to previous and current use of HRT, oral contraceptives and alternative remedies. Results: Current use of HRT was more common among women who previously used oral contraceptives (41.3%) than among women who had never used oral contraceptives (23.1%). HRT users were also more often physically active, had undergone hysterectomy and had lighter occupation than non-users. Of all women 35% were current users of HRT, half of them for at least 2 years, whereas only 5% had tried HRT and abandoned therapy. Alternative remedies were used by 5% of the women as therapy for climacteric complaints, and about four times as many women had tried such therapy but abandoned it. The only characteristic about use of alternative medicines was that they were used less often by women who had been hysterectomized. No woman treated for breast cancer used HRT and only few of them used alternative remedies. Conclusions: The prevalence of HRT use, as well as compliance, was high. Previous use of oral contraceptives probably affected the attitude towards using HRT.
引用
收藏
页码:193 / 199
页数:7
相关论文
共 50 条
  • [1] Previous oral contraceptive use and breast cancer risk according to hormone replacement therapy use among postmenopausal women
    Dumeaux, V
    Fournier, A
    Lund, E
    Clavel-Chapelon, F
    [J]. CANCER CAUSES & CONTROL, 2005, 16 (05) : 537 - 544
  • [2] Previous oral contraceptive use and breast cancer risk according to hormone replacement therapy use among postmenopausal women
    Vanessa Dumeaux
    Agnès Fournier
    Eiliv Lund
    Françoise Clavel-Chapelon
    [J]. Cancer Causes & Control, 2005, 16 : 537 - 544
  • [3] Use of oral contraceptives and hormone replacement therapy in the WHO MONICA project
    Lundberg, V
    Tolonen, H
    Stegmayr, B
    Kuulasmaa, K
    Asplund, K
    [J]. MATURITAS, 2004, 48 (01) : 39 - 49
  • [4] Screening before and during the use of oral contraceptives and hormone replacement therapy
    Crosignani, PG
    Rubin, BL
    [J]. HUMAN REPRODUCTION, 2000, 15 (02) : 485 - 492
  • [5] Oral contraceptives and hormone replacement therapy - Preface
    Emeis, JJ
    Kooistra, T
    [J]. CURRENT MEDICINAL CHEMISTRY, 2000, 7 (05) : U2 - U2
  • [6] Oral contraceptives, hormone replacement therapy and thrombosis
    Rosendaal, FR
    Helmerhorst, FM
    Vandenbroucke, JP
    [J]. THROMBOSIS AND HAEMOSTASIS, 2001, 86 (01) : 112 - 123
  • [7] Oral contraceptives, hormone replacement therapy and haemostasis
    Conard, J
    Samama, MM
    [J]. CEPHALALGIA, 2000, 20 (03) : 175 - 182
  • [8] Use of Systemic Steroids, Hormone Replacement Therapy, or Oral Contraceptives Is Associated with Decreased Implant Survival in Women
    Zou, Michelle Y.
    Cohen, Robert E.
    Ursomanno, Brendon L.
    Yerke, Lisa M.
    [J]. DENTISTRY JOURNAL, 2023, 11 (07)
  • [9] Thrombophilia and the risk of thromboembolic events in women on oral contraceptives and hormone replacement therapy
    DeSancho, Maria T.
    Dorff, Tanya
    Rand, Jacob H.
    [J]. BLOOD COAGULATION & FIBRINOLYSIS, 2010, 21 (06) : 534 - 538
  • [10] Women with thrombophilia: Assessing the risks for thrombosis with oral contraceptives or hormone replacement therapy
    Waselenko, JK
    Nace, MC
    Alving, B
    [J]. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1998, 24 : 33 - 39